2,324 results on '"Zinsmeister, Alan R."'
Search Results
2. Epidemiology, Pathophysiology, and Classification of Fecal Incontinence: State of the Science Summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Workshop
3. Aging, Obesity, and the Incidence of Diverticulitis: A Population-Based Study
4. Effects of Amitriptyline and Escitalopram on Sleep and Mood in Patients With Functional Dyspepsia
5. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial
6. Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression
7. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome–Diarrhea Without Bile Acid Malabsorption
8. High-resolution Anorectal Manometry for Identifying Defecatory Disorders and Rectal Structural Abnormalities in Women
9. Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial
10. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota
11. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial
12. Relationship Among Anal Sphincter Injury, Patulous Anal Canal, and Anal Pressures in Patients With Anorectal Disorders
13. Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus
14. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study
15. Clinical and Histologic Determinants of Mortality for Patients With Barrett’s Esophagus–Related T1 Esophageal Adenocarcinoma
16. A Randomized Trial of 5-Hydroxytryptamine4–Receptor Agonist, YKP10811, on Colonic Transit and Bowel Function in Functional Constipation
17. A Population-based Study of Incidence, Risk Factors, Clinical Spectrum, and Outcomes of Ischemic Colitis
18. Relationship Between Glycemic Control and Gastric Emptying in Poorly Controlled Type 2 Diabetes
19. Family history of mental illness or alcohol abuse and the irritable bowel syndrome
20. Quantitative Gastrointestinal and Psychological Traits Associated With Obesity and Response to Weight-Loss Therapy
21. The Epidemiology of Microscopic Colitis in Olmsted County From 2002 to 2010: A Population-Based Study
22. Effects of Clonidine in Women With Fecal Incontinence
23. Obstructive Sleep Apnea Is a Risk Factor for Barrett's Esophagus
24. Pilot trial: Pregabalin on colonic sensorimotor functions in irritable bowel syndrome
25. Outcomes of Ultrasound-Guided Trigger Point Injection for Abdominal Wall Pain
26. Yield of Repeat Endoscopy in Barrett’s Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study
27. Clinical Factors Associated With Development of Severe-Complicated Clostridium difficile Infection
28. The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients With Type 1 Diabetes Mellitus
29. Bowel Functions, Fecal Unconjugated Primary and Secondary Bile Acids, and Colonic Transit in Patients With Irritable Bowel Syndrome
30. A Controlled Trial of Gluten-Free Diet in Patients With Irritable Bowel Syndrome-Diarrhea: Effects on Bowel Frequency and Intestinal Function
31. Metabolic Syndrome as a Risk Factor for Barrett Esophagus: A Population-Based Case-Control Study
32. Phenotypic Identification and Classification of Functional Defecatory Disorders Using High-Resolution Anorectal Manometry
33. Validation of the Ulcerative Colitis Colonoscopic Index of Severity and Its Correlation With Disease Activity Measures
34. The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study
35. Endoscopic Skipping of the Distal Terminal Ileum in Crohn's Disease Can Lead to Negative Results From Ileocolonoscopy
36. Effects of Birth Cohorts on the Irritable Bowel Syndrome Support Early-Life Risk Factors
37. Lack of Familial Aggregation in Chronic Constipation Excluding Irritable Bowel Syndrome: A Population-Based Study
38. Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea
39. Functional Dyspepsia Treatment Trial (FDTT): A double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics
40. Factors Associated With Persistent and Nonpersistent Chronic Constipation, Over 20 Years
41. Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
42. Factors That Predict Relief From Upper Abdominal Pain After Cholecystectomy
43. Population Screening for Barrett Esophagus: A Prospective Randomized Pilot Study
44. A Klothoβ Variant Mediates Protein Stability and Associates With Colon Transit in Irritable Bowel Syndrome With Diarrhea
45. Screening for Barrett’s Esophagus: Results from a Population-Based Survey
46. Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome
47. A Shift in the Clinical Spectrum of Eosinophilic Gastroenteritis Toward the Mucosal Disease Type
48. Patients Dismissed From the Hospital With a Diagnosis of Noncardiac Chest Pain: Cardiac Outcomes and Health Care Utilization
49. Bowel Disturbances Are the Most Important Risk Factors for Late Onset Fecal Incontinence: A Population-Based Case-Control Study in Women
50. Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.